305 related articles for article (PubMed ID: 31956102)
21. Comprehensive Analysis of the Expression Profiles of Long Non-Coding RNAs with Associated ceRNA Network Involved in the Colon Cancer Staging and Progression.
Wu M; Li W; Huang F; Sun J; Li KP; Shi J; Yang J; Li J; Li Y; Hu N; Hu Y
Sci Rep; 2019 Nov; 9(1):16910. PubMed ID: 31729423
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
[TBL] [Abstract][Full Text] [Related]
23. Identification of prognostic factors for intrahepatic cholangiocarcinoma using long non-coding RNAs-associated ceRNA network.
Kang Z; Guo L; Zhu Z; Qu R
Cancer Cell Int; 2020; 20():315. PubMed ID: 32694937
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Luo Q; Cui M; Deng Q; Liu J
Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
[TBL] [Abstract][Full Text] [Related]
25. Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Jiang WD; Yuan PC
PLoS One; 2019; 14(8):e0220118. PubMed ID: 31369587
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.
Lei GL; Li Z; Li YY; Hong ZX; Wang S; Bai ZF; Sun F; Yan J; Yu LX; Yang PH; Yang ZY
Environ Toxicol; 2021 Nov; 36(11):2322-2332. PubMed ID: 34418280
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
28. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
29. Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.
Xu N; Cui Y; Dong J; Huang L
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):12. PubMed ID: 32645133
[TBL] [Abstract][Full Text] [Related]
30. Selecting molecular therapeutic drug targets based on the expression profiles of intrahepatic cholangiocarcinomas and miRNA-mRNA regulatory networks.
Sun B; Xie C; Zheng T; Yin D; Wang J; Liang Y; Li Y; Yang G; Shi H; Pei T; Han J; Liu L
Oncol Rep; 2016 Jan; 35(1):382-90. PubMed ID: 26498995
[TBL] [Abstract][Full Text] [Related]
31. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
[TBL] [Abstract][Full Text] [Related]
32. Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.
Wang S; Yin J; Li T; Yuan L; Wang D; He J; Du X; Lu J
Oncol Rep; 2015 Feb; 33(2):819-25. PubMed ID: 25482320
[TBL] [Abstract][Full Text] [Related]
33. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network in systemic lupus erythematosus.
Xu H; Chen W; Zheng F; Tang D; Liu D; Wang G; Xu Y; Yin L; Zhang X; Dai Y
Lupus; 2020 Apr; 29(4):398-406. PubMed ID: 32070185
[TBL] [Abstract][Full Text] [Related]
34. ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort.
Fernandes M; Marques H; Teixeira AL; Medeiros R
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008626
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
Zhang MY; Li SH; Huang GL; Lin GH; Shuang ZY; Lao XM; Xu L; Lin XJ; Wang HY; Li SP
BMC Cancer; 2015 Feb; 15():64. PubMed ID: 25880914
[TBL] [Abstract][Full Text] [Related]
36. A2M is a potential core gene in intrahepatic cholangiocarcinoma.
Zhang G; Liu X; Sun Z; Feng X; Wang H; Hao J; Zhang X
BMC Cancer; 2022 Jan; 22(1):5. PubMed ID: 34979994
[TBL] [Abstract][Full Text] [Related]
37. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
38. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
Zhang K; Zhang L; Mi Y; Tang Y; Ren F; Liu B; Zhang Y; Zheng P
Cancer Sci; 2020 Nov; 111(11):4041-4050. PubMed ID: 32860283
[TBL] [Abstract][Full Text] [Related]
39. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Cao D; Wang Y; Li D; Wang L
Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
[TBL] [Abstract][Full Text] [Related]
40. Coding-noncoding gene expression in intrahepatic cholangiocarcinoma.
Wang J; Xie H; Ling Q; Lu D; Lv Z; Zhuang R; Liu Z; Wei X; Zhou L; Xu X; Zheng S
Transl Res; 2016 Feb; 168():107-121. PubMed ID: 26297049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]